C-MET-PROTEINAGONIST
European patent · EP3059244 · In force
Register entry
- Publication number
- EP3059244
- Application number
- EP14853408
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Oct 15, 2014
- Published
- Aug 24, 2016
- Granted
- Aug 26, 2020
- Protection ends at the latest
- Oct 14, 2034
- Next annual fee due
- Oct 31, 2026
- IPC classes
- C07K 7/54 (2006.01)A61K 38/00 (2006.01)A61P 1/16 (2006.01)A61P 9/00 (2006.01)A61P 9/04 (2006.01)A61P 9/10 (2006.01)A61P 11/00 (2006.01)A61P 13/12 (2006.01)A61P 17/02 (2006.01)A61P 21/02 (2006.01)C07K 1/06 (2006.01)C07K 7/64 (2006.01)C07K 19/00 (2006.01)C12N 15/09 (2006.01)C07K 14/71 (2006.01)
- Priority
- JP 2013214771 15.10.2013
- PCT application
- PCT/JP2014/077437 15.10.2014
- PCT publication
- WO2015/056713 23.04.2015
- Filing language
- Japanese
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 1, 2025
Change
Published in Swissreg on 01.11.2025
- Nov 1, 2024
Change
Published in Swissreg on 01.11.2024
- Nov 1, 2023
Change
Published in Swissreg on 01.11.2023
- Nov 1, 2022
Change
Published in Swissreg on 01.11.2022
- Aug 26, 2020
Granted
Published in Swissreg on 26.08.2020
Parties
Inventor
ITO, Kenichiro
Tokyo 113-0033, JP
SUGA, Hiroaki
Tokyo 113-8654, JP
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.